|
HY-10013B-10mg
|
MedChemexpress LLC
|
Taranabant ((1R,2R)stereoisomer) [CAS 701977-08-4]
|
|
|
|
|
HY-10013B-2mg
|
MedChemexpress LLC
|
Taranabant ((1R,2R)stereoisomer) [CAS 701977-08-4]
|
|
|
|
|
HY-10013B-5mg
|
MedChemexpress LLC
|
Taranabant ((1R,2R)stereoisomer) [CAS 701977-08-4]
|
|
|
|
|
HY-100542-10mg
|
MedChemexpress LLC
|
D-Alpha-Hydroxyglutaric acid (disodium) [CAS 103404-90-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100542-100mg
|
MedChemexpress LLC
|
D-Alpha-Hydroxyglutaric acid (disodium) [CAS 103404-90-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100542-25mg
|
MedChemexpress LLC
|
D-Alpha-Hydroxyglutaric acid (disodium) [CAS 103404-90-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100542-5mg
|
MedChemexpress LLC
|
D-Alpha-Hydroxyglutaric acid (disodium) [CAS 103404-90-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100542-50mg
|
MedChemexpress LLC
|
D-Alpha-Hydroxyglutaric acid (disodium) [CAS 103404-90-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100615A-1mg
|
MedChemexpress LLC
|
R 80123 [CAS 133718-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-100703-1mg
|
MedChemexpress LLC
|
Pipamperone [CAS 1893-33-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100703-5mg
|
MedChemexpress LLC
|
Pipamperone [CAS 1893-33-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100742-1mg
|
MedChemexpress LLC
|
GNE-140 (racemate) [CAS 1802977-61-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100742-10mg
|
MedChemexpress LLC
|
GNE-140 (racemate) [CAS 1802977-61-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100742-100mg
|
MedChemexpress LLC
|
GNE-140 (racemate) [CAS 1802977-61-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100742-5mg
|
MedChemexpress LLC
|
GNE-140 (racemate) [CAS 1802977-61-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100742-50mg
|
MedChemexpress LLC
|
GNE-140 (racemate) [CAS 1802977-61-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100742A-10mg
|
MedChemexpress LLC
|
(R)-GNE-140 [CAS 2003234-63-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100742A-100mg
|
MedChemexpress LLC
|
(R)-GNE-140 [CAS 2003234-63-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100742A-5mg
|
MedChemexpress LLC
|
(R)-GNE-140 [CAS 2003234-63-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100742A-50mg
|
MedChemexpress LLC
|
(R)-GNE-140 [CAS 2003234-63-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100808-1g
|
MedChemexpress LLC
|
D-Serine [CAS 312-84-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100808-5g
|
MedChemexpress LLC
|
D-Serine [CAS 312-84-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100808-500mg
|
MedChemexpress LLC
|
D-Serine [CAS 312-84-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100808S-1mg
|
MedChemexpress LLC
|
D-Serine-d3 [CAS 1414348-52-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100814-1mg
|
MedChemexpress LLC
|
(R)-CPP [CAS 126453-07-4]
|
|
Neuroscience-Neurodegeneration
|
|
